Seres Therapeutics (MCRB) Reports Q2 Loss of $0.69/Share

Seres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($0.69), versus ($0.70) reported last year. Revenue for the quarter came in at $3.01 million, versus $3 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Isabella Bank added to Russell 2000 index after Nasdaq listing
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance